During this time of extremely high call volume, our team is working diligently to respond to inquiries as quickly as possible on the day they are received. 

  

If you have not received a response from our team or your submitted documents show as pending in your portal, please know these are in queue to be reviewed in the order they are received. Submitting multiple emails, portal messages, or phone calls adds time to the review process for our team and results in additional delays in our ability to respond to inquiries.  

  

To help us better assist you, please utilize one of the following options: 1. Visit your respective patient, provider, or pharmacy portal to enroll, re-enroll, or check grant status. It takes approximately 10 minutes to apply on average, and your application is acted on in real time: https://healthwellfoundation.my.salesforce-sites.com/patients.  2. Email grants@healthwellfoundation.org if your inquiry cannot be answered via the portals. 3. Request a callback through our interactive voice response system and a representative will respond to your inquiry on the same day it is received (note, this may be outside of normal business hours). 

  

We understand the importance of timely and complete responses and serving you is our number one priority. Please help us help you by submitting one inquiry only.  

  

Thank you for your patience during this time. 

Dismiss alert
By Real World Health Care Editorial Staff  |  Feb 9, 2022

What is Acute Lymphoblastic Leukemia and Whom Does it Affect?

Leukemia is a blood cancer that affects red blood cells, white blood cells and/or platelets. One type of leukemia, acute lymphoblastic leukemia (ALL) – also called acute lymphocytic leukemia and acute lymphoid leukemia – is a blood and bone marrow cancer that can affect both children and adults. In adults…more.

Categories: Leukemia
By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Oct 18, 2017

The Multiple Myeloma Landscape

Editor’s Note: This article originally appeared in Biotech Primer Weekly. For more of the science behind the headlines, please subscribe. Multiple myeloma is a cancer formed by a type of white blood cell called a plasma cell. These cells are the antibody-producing cells of our immune system and play a…more.

Categories: General, Multiple Myeloma
By Krista Zodet, President/CEO, HealthWell Foundation  |  Oct 4, 2017

New Real World Health Care Series: Multiple Myeloma Research and Treatment

Susan, from Columbia, S.C., is among the millions of Americans struggling to manage a chronic and life-altering disease without the financial means to afford needed medication. Here at HealthWell, we’re honored to be able to help Susan and other patients like her. It always warms our hearts to receive letters…more.

Categories: General, Multiple Myeloma
Close menu